Drug Trial Radar · NCT01266265
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Last checked: Nov 20, 2026Latest source record: Feb 17, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,333
Actual
Start
Dec 2010
Primary completion
Dec 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 24, 2010
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A surveillance of respiratory tract related adverse events in patients treated with Tyvaso®(treprostinil) Inhalation Solution versus other FDA approved therapies
Conditions
- Pulmonary Arterial Hypertension
Interventions
inhaled prostacyclinDrug
Tyvaso
inhaled prostacyclinDrug
As prescribed by the physician
prostacyclinDrug
As prescribed by the physician
subcutaneous and intravenous prostacyclinDrug
As prescribed by physician
oral ERADrug
As prescribed by physician
oral PDE5 inhibitorsDrug
As prescribed by physician
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevalence of Respiratory Tract-Related Adverse Events of InterestTime frame: Follow-up every 3 months
Locations
88 sites in 1 country. Site status is shown where the registry gives one.
Cardiovascular Associates, P.C.
Birmingham, Alabama
The University of Alabama at Birmingham
Birmingham, Alabama
University of South Alabama
Mobile, Alabama
Arizona Pulmonary Specialists, LTD
Phoenix, Arizona
Berkeley Cardiovascular Medical Group
Berkeley, California
Cedars-Sinai Heart Institute
Beverly Hills, California
University California San Francisco
Fresno, California
University of Southern California
Los Angeles, California
West Los Angeles VA Healthcare Center
Los Angeles, California
University of California Davis Medical Center
Sacramento, California
University of California, San Francisco
San Francisco, California
Paloma Medical Group
San Juan Capistrano, California
Santa Barbara Cottage Hospital
Santa Barbara, California
Stanford Hospital and Clinics
Stanford, California
Children's Hospital Denver
Denver, Colorado
Western States Clinical Research, Inc.
Wheat Ridge, Colorado
St. Francis Sleep Allergy & Lung
Clearwater, Florida
University of Florida
Gainesville, Florida
Pulmonary and Critical Care Associates
Jacksonville, Florida
University of Florida College of Medicine Jacksonville
Jacksonville, Florida
Mayo Clinic Jacksonville
Jacksonville, Florida
Miami Center for Cardiovascular Disease
Miami, Florida
Mount Sinai Medical Center
Miami Beach, Florida
Central Florida Pulmonary Group, P.A.
Orlando, Florida
Orlando Heart Center
Orlando, Florida
Cleveland Clinic Florida
Weston, Florida
Emory University School of Medicine
Atlanta, Georgia
Georgia Lung Associates, PC
Austell, Georgia
Northwestern Medical Center
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Illinois at Chicago
Chicago, Illinois
Midwest Heart Foundation
Oakbrook Terrace, Illinois
Indiana University Hospital
Carmel, Indiana
University of Iowa
Iowa City, Iowa
Mercy Hospital
Iowa City, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Kentuckiana Pulmonary Associates
Louisville, Kentucky
University of Maryland
Baltimore, Maryland
Johns Hopkins University
Baltimore, Maryland
Tufts - New England Medical Center
Boston, Massachusetts
Showing 40 of 88 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.